CPHI [CHINA PHARMAS,] DEFA14A: (Original Filing)
[Payment of Filing Fee (Check the appropriate box): þ No fee required. o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (1)]
CPHI [CHINA PHARMAS,] DEFA14A: Payment of Filing Fee (Check the appropriate box):
[Payment of Filing Fee (Check the appropriate box): þ No fee required. o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (1)]
CPHI [CHINA PHARMAS,] DEF 14A: (Original Filing)
[Payment of Filing Fee (Check the appropriate box): þ No fee required. o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.]
CPHI [CHINA PHARMAS,] DEF 14A: Payment of Filing Fee (Check the appropriate box):
[Payment of Filing Fee (Check the appropriate box): þ No fee required. o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.]
CPHI [CHINA PHARMAS,] DEFA14A: (Original Filing)
[Payment of Filing Fee (Check the appropriate box): No fee required. o Feemputed on table below per Exchange Act Rules14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction applies: (2)gregate number of securities to which transaction applies: (3) (4) Proposed maximumgregate value of transaction:]
CPHI [CHINA PHARMAS,] DEFA14A: Payment of Filing Fee (Check the appropriate box):
[Payment of Filing Fee (Check the appropriate box): No fee required. o Feemputed on table below per Exchange Act Rules14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction applies: (2)gregate number of securities to which transaction applies: (3) (4) Proposed maximumgregate value of transaction:]
CPHI [CHINA PHARMAS,] DEF 14A: (Original Filing)
[Payment of Filing Fee (Check the appropriate box): No fee required. o Feemputed on table below per Exchange Act Rules14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction applies: _______________________________________________________________________________________________ (2)gregate number of securities to which transaction applies: _______________________________________________________________________________________________ (3) _______________________________________________________________________________________________ (4) Proposed maximumgregate value of transaction:]
CPHI [CHINA PHARMAS,] DEF 14A: Payment of Filing Fee (Check the appropriate box):
[Payment of Filing Fee (Check the appropriate box): No fee required. o Feemputed on table below per Exchange Act Rules14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction applies: _______________________________________________________________________________________________ (2)gregate number of securities to which transaction applies: _______________________________________________________________________________________________ (3) _______________________________________________________________________________________________ (4) Proposed maximumgregate value of transaction:]
CPHI [CHINA PHARMAS,] 8-K: (Original Filing)
[--------------- FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): October 10, 2013 CHINA PHARMA HOLDINGS, INC. --------------------------------------- Nevada 001-34471 73-1564807 (State or other jurisdiction (Commission File No.) (IRS Employer of Incorporation) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) Company Previous 8-K HBM Eide Bailly As previously disclosed]
CPHI [CHINA PHARMAS,] 8-K: ————— FORM 8-K CURRENT REPORTte of Report (Date
[--------------- FORM 8-K CURRENT REPORTte of Report (Date of earliest event reported): October 10, 2013 CHINA PHARMAS, --------------------------------------- Nevada 001-34471 73-1564807 (State or other jurisdiction (Commission File No.) (IRS Employer oforporation) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86 898-6681-1730 (China) Engagement of New Independent Accountant]
